Remove 2016 Remove Ethics Remove Healthcare Remove Patients
article thumbnail

Staying abreast of regulations with NGS?based viral safety for faster, safer and more ethical lot release of our vaccines

European Pharmaceutical Review

As the healthcare sector grows, there is a clear trend towards the expansion of biologic therapeutic drugs and vaccines like the one developed by Novavax. Any modification in the manufacturing process could drastically impact the structure or the effectiveness of the product for patients, inciting a major public health threat.

Ethics 81
article thumbnail

Cyberwarfare: A Healthcare Marketers’ Guide in the Fight for Corporate Reputation

PM360

Traditional approaches to mitigating cyber events—even ones that have been successfully implemented on behalf of other sectors—are falling short of the vulnerabilities being created by criminals in the healthcare field. They’ve disabled health systems’ ability to care for their patients. So how should marketers prepare?

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Bill could enhance UK clinical trial regulation

European Pharmaceutical Review

Benefits of The Future Clinical Trials Bill Chiefly, the Bill’s goal is to increase patient participation and overall, ensure clinical trials have the highest levels of safety while enabling greater regulatory pragmatism, the author explained. This is according to a 2016 paper published in Clinical and Translational Oncology.

Ethics 84
article thumbnail

Improving Access to Medicine: The Role of Pharma Companies in Emerging Markets

PM360

As shareholders and consumers demand greater transparency, accountability, and ethical behavior from corporations, pharmaceutical companies are expected to play a role in addressing these issues. These partnerships can be with local governments, healthcare providers, local startups, and non-governmental organizations.

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

One of the biggest opportunities presented by big data in the pharmaceutical industry is the ability to gain insights into patient needs and preferences. One of the biggest challenges is ensuring that patient privacy is protected. 1 (2016) 3. Another challenge is the sheer volume of data that companies must manage. 8 (2018) 2.

article thumbnail

The Use of Big Data in Pharmaceutical Marketing: Opportunities and Challenges

Pharma Marketing Network

One of the biggest opportunities presented by big data in the pharmaceutical industry is the ability to gain insights into patient needs and preferences. One of the biggest challenges is ensuring that patient privacy is protected. 1 (2016) 3. Another challenge is the sheer volume of data that companies must manage. 8 (2018) 2.

article thumbnail

Why early participant engagement is now a top priority in genetic disease research

pharmaphorum

In 2016, scientists behind a study called the Resilience Project analysed genetic data from 589,000+ people and found 13 adults who carried genetic variants that should have resulted in serious – even deadly – childhood disease, but who were apparently healthy.